business
Guardian Pharmacy Services Q1 Earnings Call Highlights
Key takeaways
- Guardian Pharmacy Services Q1 Earnings Call Highlights Market Beat Mon, May 11, 2026 at 12:14 AM GMT+7 7 min read GRDN Guardian Pharmacy Services logo Key Points Interested in Guardian Pharmacy Services, Inc.?
- Management said the IRA transition has largely matched expectations and raised full-year adjusted EBITDA guidance to $123 million-$127 million while keeping revenue guidance unchanged at $1.4 billion-$1.42 billion;
- 5 Small-Cap Stocks With Impressive Growth and Upside Potential
Guardian Pharmacy Services Q1 Earnings Call Highlights Market Beat Mon, May 11, 2026 at 12:14 AM GMT+7 7 min read GRDN Guardian Pharmacy Services logo Key Points Interested in Guardian Pharmacy Services, Inc.? Here are five stocks we like better.
Guardian Pharmacy Services said it had a solid Q1 2026 despite the Inflation Reduction Act’s drug pricing pressure, reporting revenue of $336.6 million, up 2% year over year, and double-digit growth in residents and script volumes.
The company’s profitability improved sharply, with gross profit up 19% to $76 million and adjusted EBITDA up 27% to $29.8 million, helped by favorable payer dynamics and a one-time manufacturer inventory credit tied to the IRA.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Schaeffler AG Q1 2026 beats EPS forecast by 237%
Investing.com
Earnings call transcript: IPC’s Q1 2026 results show solid performance
Investing.com
Earnings call transcript: Backblaze Q1 2026 earnings beat boosts stock
Investing.com
Earnings call transcript: Allison Transmission beats Q1 2026 EPS forecasts by 24.76%
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop